|
SNX13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.067770E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.680160E-02 |
| Normal-vs-Stage2 |
5.757000E-01 |
| Normal-vs-Stage3 |
1.542380E-03 |
| Normal-vs-Stage4 |
7.223300E-03 |
| Stage1-vs-Stage2 |
5.354200E-01 |
| Stage1-vs-Stage3 |
1.654760E-01 |
| Stage1-vs-Stage4 |
3.509600E-01 |
| Stage2-vs-Stage3 |
1.655840E-01 |
| Stage2-vs-Stage4 |
2.472800E-01 |
| Stage3-vs-Stage4 |
8.713000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.596700E-03 |
| Normal-vs-AfricanAmerican |
2.348000E-01 |
| Normal-vs-Asian |
3.764500E-02 |
| Caucasian-vs-AfricanAmerican |
4.848000E-01 |
| Caucasian-vs-Asian |
6.779600E-01 |
| AfricanAmerican-vs-Asian |
5.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.415800E-03 |
| Normal-vs-Female |
2.467800E-01 |
| Male-vs-Female |
3.465200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.954500E-02 |
| Normal-vs-Extreme_Weight |
5.376200E-02 |
| Normal-vs-Obese |
4.593900E-02 |
| Normal-vs-Extreme_Obese |
3.531000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.435400E-01 |
| Normal_Weight-vs-Obese |
5.548000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.581800E-01 |
| Extreme_Weight-vs-Obese |
8.070800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.868800E-01 |
| Obese-vs-Extreme_Obese |
8.646200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.975900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.754600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.420050E-03 |
| Normal-vs-Age(81-100Yrs) |
1.958830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.613400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.495400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.615200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.035600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.634400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.503200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.950230E-01 |
| Normal-VS-Type2 PRCC |
1.594970E-04 |
| Normal-VS-KIRP CIMP |
1.178390E-03 |
| Normal-VS-Unclassified PRCC |
3.638200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.141300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.158210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.303800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.251600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.926400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.158800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.29770000000396E-05 |
| Normal-vs-N1 |
1.015990E-03 |
| Normal-vs-N2 |
1.003970E-02 |
| N0-vs-N1 |
8.863800E-01 |
| N0-vs-N2 |
4.235400E-01 |
| N1-vs-N2 |
4.049200E-01 |
|
|
